Longevitix Partnered With Longevity Expert Eric Verdin
The newly founded health company has brought on the Buck Institute CEO to guide its artificial intelligence platform.
Updated on Oct. 13, 2026 in Nutrition
Live Poll
Do you trust AI-driven tools to provide better personalized preventive healthcare for your own needs?
Longevitix, a clinical intelligence platform for preventive medicine, announced a strategic collaboration with Dr. Eric Verdin. The partnership aims to enhance the company's AI-driven approach to longevity.
Why it matters
By integrating medical records and wearable data, the collaboration seeks to advance predictive health models that shift medicine toward preventative care.
Longevitix utilizes a clinical intelligence platform that aggregates medical records, lab results, imaging, and wearable data. The firm was officially founded in early 2025 by Effie Arditi, Gaby Hayon, and Dr. Neil Panchal.
The players
Eric Verdin
He serves as the President and CEO of the Buck Institute for Research on Aging.
Longevitix
This is a clinical intelligence platform company founded in 2025 that focuses on preventive and longevity medicine.
Effie Arditi
She is one of the three co-founders who launched the longevity health company in early 2025.
Gaby Hayon
She is a co-founder of the New York-based health technology firm Longevitix.
Neil Panchal
He is a doctor and co-founder of the clinical intelligence platform Longevitix.
The details
Dr. Eric Verdin will provide scientific guidance to refine the company's platform, which synthesizes patient data to create a comprehensive view of biological aging. This infrastructure is designed to assist clinicians in developing personalized longevity interventions based on individual lifestyle and diagnostic inputs.
Timeline
Longevitix was founded in early 2025.
The collaboration was officially announced on October 13, 2026.
Health Landscape
This collaboration reflects a broader trend of integrating academic research from institutions like the Buck Institute for Research on Aging into commercial preventive health startups. It signals an effort to standardize longevity medicine through high-level scientific oversight.
Patients using the Longevitix platform may benefit from more sophisticated risk assessments as the company integrates expert medical insights into its algorithms. This could eventually lead to more personalized preventative health plans tailored to individual lab results and lifestyle data.
The takeaway
Longevity medicine is increasingly moving toward data-integrated platforms that synthesize lifestyle and medical records. Consumers should look for evidence-based platforms that involve recognized scientific advisors to ensure their health data is being managed accurately.
Further reading
Learn more about the latest innovations in health and longevity through our Nutrition section.
More information
Review additional details regarding the technology and mission on the Longevitix company information page.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you trust AI-driven tools to provide better personalized preventive healthcare for your own needs?
